Synthesis of Cyclopentenyl Carbocyclic Nucleosides as Potential Antiviral Agents Against Orthopoxviruses and SARS
Citations Over TimeTop 10% of 2006 papers
Abstract
A practical and convenient methodology for the synthesis of chiral cyclopentenol derivative (+)-12a has been developed as the key intermediate that was utilized for the synthesis of biologically active carbocyclic nucleosides. The selective protection of allylic hydroxyl group followed by the ring-closing metathesis (RCM) reaction with Grubbs catalysts provided (+)-12a on a 10 g scale with 52% overall yield from D-ribose (4). The key intermediate (+)-12a was utilized for the synthesis of unnatural five-membered ring heterocyclic carbocyclic nucleosides. The newly synthesized 1,2,3-triazole analogue (17c) exhibited potent antiviral activity (EC(50) 0.4 microM) against vaccinia virus and moderate activities (EC(50) 39 microM) against cowpox virus and severe acute respiratory syndrome coronavirus (SARSCoV) (EC(50) 47 microM). The 1,2,4-triazole analogue (17a) also exhibited moderate antiviral activity (EC(50) 21 microM) against SARSCoV.
Related Papers
- → And now for something completely different: from 2019-nCoV and COVID-19 to 2020-nMan(2020)27 cited
- → ОПЫТ ОЦЕНКИ ПОПУЛЯЦИОНОГО ИММУНИТЕТА К SARS-CoV-2 СРЕДИ НАСЕЛЕНИЯ ЛЕНИНГРАДСКОЙ ОБЛАСТИ В ПЕРИОД ЭПИДЕМИИ COVID-19(2020)7 cited
- → Про участь вчених НАН України в протидії COVID-19. Створення вакцин проти SARS-CoV-2 та COVID-19 в Україні: стан, проблеми та перспективи(2021)1 cited
- → Pediatricians Face Challenges in Diagnosing Post-COVID-19 Conditions (Long COVID)(2023)